September 23, 2014 / 10:59 AM / 3 years ago

BUZZ-Tekmira Pharmaceuticals Corp: Ebola drug shows promise

1 Min Read

** Canadian drugmaker's U.S.-listed shares up 8.4 pct at $25.60 premarket

** Company's Ebola drug shows promising signs after being administered to doctor infected with virus in West Africa, Nebraska Medical Center said on Monday

** Drug, code named TKM-Ebola, was authorized to be used by U.S. and Canadian regulators in patients with confirmed or suspected Ebola infection

** Drug among several experimental Ebola drugs to be tested in West Africa to fast track trials, global health charity Wellcome Trust said

** Up to Monday's close, stock had risen 65.5 pct since Aug. 7, when U.S. Food and Drug Administration lifted partial hold on Tekmira's Ebola drug

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below